Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151749 · ClinicalTrials.gov registry record · Phase 3
WelChol® and Insulin in Treating Patients With Type 2 Diabetes
A Phase 3 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 3
- Development phase
- 260
- Enrollment target
NCT00151749: Completed Phase 3 study, sponsored by Daiichi Sankyo.
NCT00151749 is a Phase 3 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 260 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00151749, a Phase 3 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 260 participants
- Enrollment target
Study Summary
The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
Interventions
- DRUG Colesevelam hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
What the finished NCT00151749 record still lists
NCT00151749 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 1 intervention - of which Colesevelam hydrochloride is the first listed.
NCT00151749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00151749 about?
NCT00151749 is a clinical study titled "WelChol® and Insulin in Treating Patients With Type 2 Diabetes". The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
What is the current status of trial NCT00151749?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 260 participants. The study started on 2004-06. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00151749?
The interventions under investigation include: Colesevelam hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00151749?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00151749's enrollment target sits among peer trials
260 1230th of 2000 higher than 767 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia